Information  X 
Enter a valid email address

Company Name matching 'ObsEva SA'

Date
Time Source
Company
Announcement
08 Nov 2018 6:15 am GNW     ObsEva SA ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update
07 Nov 2018 6:30 am GNW     ObsEva SA ObsEva SA to Participate in November Investor Conferences
31 Oct 2018 6:30 am GNW     ObsEva SA ObsEva SA to Hold Third Quarter 2018 Financial Results and Business Update Call on November 8, 2018
09 Oct 2018 9:15 pm GNW     ObsEva SA ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting
05 Oct 2018 6:00 am GNW     ObsEva SA ObsEva SA Announces Phase 3 IMPLANT 2 Clinical Trial Results of Nolasiban in IVF to be Presented at Annual ASRM Meeting Tuesday October 9, 2018
03 Oct 2018 6:00 am GNW     ObsEva SA ObsEva SA reports additional positive Phase 3 results of IMPLANT 2 trial showing significant increase of Live Birth Rate (LBR) following IVF with Single Embryo Transfer (SET)
28 Sep 2018 6:00 am GNW     ObsEva SA Final results of ObsEva SA Phase 2b EDELWEISS trial of Linzagolix show sustained efficacy and Bone Mineral Density safety, for the treatment of endometriosis-associated pain
28 Aug 2018 6:30 am GNW     ObsEva SA ObsEva SA to Participate in September Investor Conferences
10 Aug 2018 6:30 am GNW     ObsEva SA ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 14-15, 2018
08 Aug 2018 6:00 am GNW     ObsEva SA ObsEva Reports Second Quarter 2018 Financial Results and Provides Business Update
31 Jul 2018 6:30 am GNW     ObsEva SA ObsEva SA to Hold Second Quarter 2018 Financial Results and Business Update Call on August 8, 2018
25 Jul 2018 6:30 am GNW     ObsEva SA ObsEva Expands Executive Team Hiring a Chief Commercial Officer
13 Jul 2018 6:30 am GNW     ObsEva SA ObsEva SA to start trading today on the SIX Swiss Exchange
06 Jul 2018 6:30 am GNW     ObsEva SA ObsEva SA Shares to Begin Trading on SIX Swiss Exchange
20 Jun 2018 7:49 am GNW     ObsEva SA ObsEva Announces Pricing of Follow-on Public Offering
18 Jun 2018 9:31 pm GNW     ObsEva SA ObsEva Announces Launch of Proposed Follow-on Public Offering
  12:00 pm GNW     ObsEva SA ObsEva SA Achieves Primary and Secondary Endpoints for EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis
15 Jun 2018 9:00 pm GNW     ObsEva SA ObsEva SA to Hold Investor Call to Announce Topline Results of the EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis-Associated Pain on Monday June 18, 2018
01 Jun 2018 12:00 pm GNW     ObsEva SA ObsEva SA to Seek SIX Share Listing
31 May 2018 12:00 pm GNW     ObsEva SA ObsEva SA to Participate in Jefferies Global Healthcare Conference June 5-8, 2018
16 May 2018 12:00 pm GNW     ObsEva SA ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update
08 May 2018 12:00 pm GNW     ObsEva SA ObsEva SA to Hold First Quarter 2018 Financial Results and Business Update Call on May 16, 2018
23 Apr 2018 12:00 pm GNW     ObsEva SA ObsEva Announces Upcoming Presentations Related to its Endometriosis and Uterine Fibroid Development Programs with its Novel Oral GnRH Receptor Antagonist OBE2109 (KLH-2109)
16 Apr 2018 12:00 pm GNW     ObsEva SA ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) April 26, 2018 in New York City
26 Mar 2018 12:00 pm GNW     ObsEva SA ObsEva SA to Participate in the H.C. Wainwright Annual Global Life Sciences Conference April 8-10, 2018
09 Mar 2018 1:47 pm GNW     ObsEva SA ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update
  12:00 pm GNW     ObsEva SA ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update
02 Mar 2018 12:00 pm GNW     ObsEva SA ObsEva SA to Hold Fourth Quarter and Year-end 2017 Financial Results and Business Update Call on March 9, 2018
01 Mar 2018 12:00 pm GNW     ObsEva SA ObsEva Announces Presentations Related to its Pre-term labor (PTL) Development Program at SRI 2018 Annual Meeting
26 Feb 2018 12:00 pm GNW     ObsEva SA ObsEva SA Reports Positive Topline Results from IMPLANT2 Phase 3 Clinical Trial of Nolasiban in IVF
23 Feb 2018 9:00 pm GNW     ObsEva SA ObsEva SA to Hold Investor Call to announce Topline Results of the IMPLANT2 phase 3 Clinical Trial of Nolasiban in IVF/ICSI on Monday February 26, 2018
07 Feb 2018 12:00 pm GNW     ObsEva SA ObsEva SA to present at the LEERINK Partners 7th Annual Global Healthcare Conference February 14th 2018
01 Feb 2018 12:00 pm GNW     ObsEva SA Dr. Ernest Loumaye, CEO of ObsEva SA returns to work following a personal leave for medical reasons
05 Jan 2018 12:00 pm GNW     ObsEva SA ObsEva SA to Participate in JP Morgan Healthcare Conference January 8 - 11, 2018
07 Dec 2017 12:00 pm GNW     ObsEva SA ObsEva SA to Participate in BMO Healthcare Conference December 14th 2017
05 Dec 2017 12:00 pm GNW     ObsEva SA ObsEva Initiates PROLONG, the Phase 2a Clinical Trial of OBE022 in Preterm Labor
14 Nov 2017 12:00 pm GNW     ObsEva SA ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update
07 Nov 2017 12:00 pm GNW     ObsEva SA ObsEva SA Announces the Completion of Patient Recruitment in the EDELWEISS Phase 2b Clinical Trial of OBE2109 for the Treatment of Endometriosis
31 Oct 2017 11:00 am GNW     ObsEva SA ObsEva SA to Hold Third Quarter 2017 Financial Results and Business Update Call on November 14, 2017 and Present at Credit Suisse and Jefferies Investor Conferences in November
10 Oct 2017 1:00 pm GNW     ObsEva SA ObsEva SA Announces $60.0 Million Private Placement with Existing and New Investors
11 Sep 2017 12:00 pm GNW     ObsEva SA ObsEva SA Announces Presentation Related to its PGF2alpha Receptor Antagonist at ACCP 2017 Annual Meeting
06 Sep 2017 12:00 pm GNW     ObsEva SA ObsEva SA Announces the Completion of Patient Recruitment in the IMPLANT2 Phase 3 Clinical Trial in Assisted Reproductive Technology Ahead of Schedule
30 Aug 2017 12:00 pm GNW     ObsEva SA ObsEva SA to Attend Baird Global Healthcare Conference and Rodman & Renshaw Annual Global Investment Conference in NYC
15 Aug 2017 9:05 pm GNW     ObsEva SA ObsEva Reports Second Quarter 2017 Financial Results and Provides Business Update
07 Aug 2017 12:00 pm GNW     ObsEva SA ObsEva SA to Hold Second Quarter 2017 Financial Results/Business Update Call on August 15, 2017 and Present at Wedbush PacGrow Healthcare Conference in NYC on August 16, 2017
23 Jun 2015 7:30 am GNW     ObsEva SA ObsEva Announces Recruitment of the First Patient in TERM Phase 2 Study
18 Nov 2014 7:30 am GNW     ObsEva SA ObsEva Announces the Initiation of a Pivotal Ph...
10 Sep 2014 7:30 am GNW     ObsEva SA ObsEva SA appoints Ben T.G. Tan as VP Commercia...
23 Jul 2014 7:30 am GNW     ObsEva SA ObsEva SA announced today it was granted JEDI s...
29 Aug 2013 7:30 am GNW     ObsEva SA ObsEva SA announces CHF 32 Million Series A fun...


Company Announcements Archive »

 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t